Correlation of Blood T-Cells to Intratumoural Density and Location of CD3+ and CD8+ T-Cells in Colorectal Cancer
- 1Gastrointestinal Translational Research Unit, Molecular Laboratory, Stavanger University Hospital, Stavanger, Norway
- 2Centre for Organelle Research (CORE), University of Stavanger, Stavanger, Norway
- 3Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway
- 4Department of Pathology, Stavanger University Hospital, Stavanger, Norway
- 5Department of Clinical Medicine, University of Bergen, Bergen, Norway
- Correspondence to: Professor Kjetil Søreide MD, Ph.D., Department of Gastrointestinal Surgery, Stavanger University Hospital, POB 8100, N-4068 Stavanger, Norway. Tel: +47 51518330, Fax: +47 51519919, e-mail: ksoreide{at}mac.com
Abstract
Aim: To test the feasibility of conducting parallel analyses of circulating T-cells in blood and intratumoural T-cells in colorectal cancer. A pre-operative ‘liquid biopsy’ to determine immune status would facilitate clinical decision-making. Materials and Methods: A total of 18 patients with stage I-III colorectal cancer (CRC) were included. Blood was analyzed for T-cell type (CD3+, CD4+ and CD8+) and count using flow cytometry. Intratumoural T-cells were stained using immunohistochemistry and quantified by digital pathology. Tumour location was defined as invasive front (IF) or tumour center (TC). Results: The number of CD3+ and CD4+ T-cells in pre-surgical blood samples correlated with the number of CD3+ T-cells found in the IF (Spearman ϱ=0.558, p<0.05 and 0.598, p<0.01 respectively) and CD3+ in the TC (ϱ=0.496, p<0.05, and ϱ=0.637, p<0.01, respectively). A strong correlation was found between CD4+ cells in blood and CD8+ T-cells found in the TC and IF (ϱ=0.602 and ϱ=0.591, p<0.01). Conclusion: There is a correlation between blood CD3+ and CD4+ T-cells and the T-cells found at the TC and IF.
- Colorectal cancer
- T-cells
- tumour center
- tumour invasive front
- CD4+
- CD8+
- CD3+
- liquid biopsies
- cancer immune response
- Received November 27, 2016.
- Revision received December 30, 2016.
- Accepted January 10, 2017.
- Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved







